Literature DB >> 19813075

Concomitant rectal cancer and abdominal aortic aneurysm: a management strategy.

A S Ward1, A Deans, B J Moran.   

Abstract

The simultaneous occurrence of abdominal aortic aneurysm and rectal cancer is uncommon but represents a therapeutic dilemma. We report two patients in whom endovascular stenting of the aneurysm was not feasible. These patients were managed by an initial retroperitoneal aortic repair followed a few weeks later by an ultra low anterior resection.

Entities:  

Mesh：

Year:  2009        PMID： 19813075     DOI： 10.1007/s10151-009-0542-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


  12 in total

Review 1.  Priority of resection in concomitant abdominal aortic aneurysm (AAA) and colorectal cancer (CRC): review of the literature and experience of our clinic.

Authors:  D Kiskinis; C Spanos; N Melas; G Efthimiopoulos; N Saratzis; I Lazaridis; G Gkinis
Journal:  Tech Coloproctol       Date:  2004-11       Impact factor: 3.781

Review 2.  Management of synchronous abdominal aortic aneurysm and complicating colorectal cancer.

Authors:  Christina Bali; Miltiadisi Matsagas; Haralampos Harissis; Nicolaos Lagos; Angelos M Kappas
Journal:  Vascular       Date:  2006 Mar-Apr       Impact factor: 1.285

3.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Concomitant colorectal cancer and abdominal aortic aneurysm: evolution of treatment paradigm in the endovascular era.

Authors:  Peter H Lin; Neal R Barshes; Daniel Albo; Panagiotis Kougias; David H Berger; Tam T Huynh; Scott A LeMaire; Alan Dardik; W Anthony Lee; Joseph S Coselli
Journal:  J Am Coll Surg       Date:  2008-02-11       Impact factor: 6.113

5.  One-stage surgical management of concomitant abdominal aortic aneurysm and gastric or colorectal cancer.

Authors:  Kenji Matsumoto; Takaya Murayama; Kazuhito Nagasaki; Koji Osumi; Katsunori Tanaka; Makoto Nakamaru; Masaki Kitajima
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

6.  The high prevalence of colorectal neoplasms in preoperative patients with abdominal aortic aneurysm or peripheral artery disease.

Authors:  K Yamamoto; T Miyata; H Nagawa
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-11-28       Impact factor: 7.069

7.  Management of patients with colorectal cancer and concomitant abdominal aortic aneurysm.

Authors:  N N Baxter; A A Noel; K Cherry; B G Wolff
Journal:  Dis Colon Rectum       Date:  2002-02       Impact factor: 4.585

8.  Treatment of complex aneurysmal disease with fenestrated and branched stent grafts.

Authors:  C D Bicknell; N J W Cheshire; C V Riga; P Bourke; J H N Wolfe; R G J Gibbs; M P Jenkins; M Hamady
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-12-01       Impact factor: 7.069

9.  Treatment of abdominal aortic aneurysm associated with colorectal cancer: presentation of 14 cases and literature review.

Authors:  G F Veraldi; A M Minicozzi; F Leopardi; V Ciprian; B Genco; R Pacca
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

10.  Endovascular versus open surgical repair of abdominal aortic aneurysm with concomitant malignancy.

Authors:  Massimo Porcellini; Piero Nastro; Umberto Bracale; Stephen Brearley; Pasquale Giordano
Journal:  J Vasc Surg       Date:  2007-07       Impact factor: 4.268
View more
  2 in total

1.  Concomitant abdominal aortic aneurysm and rectal cancer: a treatment dilemma.

Authors:  A Madabhushi; R J Gusberg
Journal:  Tech Coloproctol       Date:  2009-12       Impact factor: 3.781

2.  Synchronous Gastrointestinal Tumor and Abdominal Aortic Aneurysm or Dissection Treated with Endovascular Aneurysm Repair Followed by Tumor Resection.

Authors:  Bo Zhang; Ketong Wu; Yang Liu; Haiyang Lai; Zhaofei Zeng
Journal:  Gastroenterol Res Pract       Date:  2019-01-06       Impact factor: 2.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.